Timolol Maleate Ophthalmic Gel Forming Solution Solution, Gel Forming / Drops
Product Images NDC 68083-458

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate Ophthalmic Gel Forming Solution (NDC 68083-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Timolol-spl-carton-label (Timolol Spl Carton Label)

Packaging label for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%, topical eye drops. Each 5 mL bottle contains timolol equivalent to 0.25% concentration (3.4 mg/mL timolol maleate). The label includes dosage directions, storage instructions, and manufacturer information for Gland Pharma Limited, India, with a barcode and NDC 68083-457-01.*

FDA Label Image

Timolol-spl-container-label (Timolol Spl Container Label)

Label for Timolol Maleate Ophthalmic Gel Forming Solution 0.25%, a 5 mL sterile eye drop solution for topical ophthalmic use. The label includes dosage strength (0.25%), NDC 68083-457-01, storage instructions (15° to 25°C, avoid freezing, protect from light), and is manufactured by Gland Pharma Limited. The label also states Rx Only and usual adult dosage guidelines.*

FDA Label Image

Timolol-spl-figure-1 (Timolol Spl Figure 1)

The image contains two line graphs showing mean intraocular pressure (IOP) and standard deviation over weeks in a U.S. study. The top graph displays IOP at trough time, and the bottom graph shows IOP at peak time. Data compares Timolol Maleate Ophthalmic Gel Forming Solution 0.5% once daily versus Timoptic 0.5% twice daily, with IOP measured in mm Hg over a 24-week period.*

FDA Label Image

Timolol-spl-figure-2 (Timolol Spl Figure 2)

Two line graphs from an international study comparing intraocular pressure (mm Hg) over 24 weeks between TIMOLOL-GFS 0.5% gel forming solution and TIMOPTIC 0.5% b.i.d. The top graph shows TIME-Trough (Hour 0) measurements, and the bottom graph shows TIME-Peak (Hour 2) measurements, each with error bars indicating variability.*

FDA Label Image

Timolol-spl-figure-a (Timolol Spl Figure A)

An instructional illustration depicting a hand holding an ophthalmic drop bottle with an arrow showing the application of a drop from the bottle tip. The image suggests the action of squeezing the bottle to dispense a drop, likely for timolol maleate ophthalmic gel forming solution.*

FDA Label Image

Timolol-spl-figure-b (Timolol Spl Figure B)

Illustration showing a person administering ophthalmic gel forming solution eye drops into the eye. The hand is positioned near the lower eyelid with a drop about to be instilled, demonstrating the correct technique for eye drop application.*

FDA Label Image

Timolol-spl-figure-c (Timolol Spl Figure C)

An instructional line drawing showing a hand holding and preparing to apply eye drops to an eye. The image depicts proper technique for administering ophthalmic gel forming solution via drops into the eye.*

FDA Label Image

Timolol-spl-structure (Timolol Spl Structure)

Chemical structure of timolol maleate ophthalmic gel forming solution's active ingredient, timolol maleate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.